0001209191-23-044635.txt : 20230804 0001209191-23-044635.hdr.sgml : 20230804 20230804172052 ACCESSION NUMBER: 0001209191-23-044635 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230802 FILED AS OF DATE: 20230804 DATE AS OF CHANGE: 20230804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boudreau Helen M CENTRAL INDEX KEY: 0001661481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36279 FILM NUMBER: 231144982 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cara Therapeutics, Inc. CENTRAL INDEX KEY: 0001346830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-406-3700 MAIL ADDRESS: STREET 1: 4 STAMFORD PLAZA STREET 2: 107 ELM STREET 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 FORMER COMPANY: FORMER CONFORMED NAME: Cara Therapeutics Inc DATE OF NAME CHANGE: 20051213 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-02 0 0001346830 Cara Therapeutics, Inc. CARA 0001661481 Boudreau Helen M C/O CARA THERAPEUTICS, INC. 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL STAMFORD CT 06902 1 0 0 0 0 Stock Option (Right to Buy) 3.09 2023-08-02 4 A 0 155747 0.00 A 2033-08-02 Common Stock 155747 155747 D This option shall vest and become exercisable in twelve (12) equal quarterly installments beginning on August 2, 2023 such that the option will be fully vested and exercisable on August 2, 2026, subject to the Reporting Person's continued service to the Issuer on each such date. /s/Darren DeStefano, Attorney-in-Fact 2023-08-04